普洛药业：与安帝康生物签订战略合作框架协议 寻求在创新药物方向更多长期合作项目

Core Viewpoint - Pro Pharmaceutical (000739) has signed a strategic cooperation framework agreement with Jiaxing Andikang Biotechnology Co., Ltd. to enhance long-term collaboration in innovative drug development and improve market competitiveness and supply stability [1] Group 1 - The agreement aims to establish a strategic partnership focused on innovative drug projects [1] - Both companies seek to enhance their competitive edge in the pharmaceutical industry through this collaboration [1] - The partnership is expected to strengthen the drug market's competitive advantages and ensure stable supply capabilities [1]